Lactobacillus reuteri NCIMB 30242

Lactobacillus reuteri NCIMB 30242 is a probiotic strain that produces bile salt hydrolase enzymes to break down cholesterol and improve cardiovascular health. This strain enhances gut microbiome diversity while supporting healthy cholesterol metabolism through direct enzymatic action.

Category: Other Evidence: 8/10 Tier: Tier 1 (authoritative)
Lactobacillus reuteri NCIMB 30242 — Hermetica Encyclopedia

Origin & History

Lactobacillus reuteri NCIMB 30242 is a probiotic strain known for its ability to survive in the gastrointestinal tract and its potential cholesterol-lowering properties. It is found in the human gut and some fermented foods.

Historical & Cultural Context

Probiotics like Lactobacillus reuteri have been used in fermented foods for centuries, valued for their health benefits across various cultures.

Health Benefits

- Supports cardiovascular health by potentially lowering cholesterol levels, with studies showing up to a 9% decrease in LDL cholesterol. It promotes heart health. - Enhances gut health by increasing the diversity of beneficial bacteria, which can improve digestion and nutrient absorption. It supports a balanced microbiome. - Boosts immune function by enhancing the activity of macrophages, which helps the body combat infections more effectively. It strengthens immune resilience. - Reduces inflammation by modulating the immune response, which can alleviate symptoms of chronic inflammatory diseases. It promotes overall wellness. - Improves skin health by reducing oxidative stress, which can decrease acne severity and improve skin texture. It supports a radiant complexion. - Aids in weight management by influencing the gut hormones that regulate appetite, potentially reducing hunger and caloric intake. It supports a healthy metabolism. - Enhances mental clarity by supporting the gut-brain axis, which can improve cognitive function and mood. It promotes mental acuity and emotional balance.

How It Works

Lactobacillus reuteri NCIMB 30242 produces bile salt hydrolase (BSH) enzymes that deconjugate bile acids in the intestine, forcing the liver to use cholesterol to synthesize new bile acids and lowering serum cholesterol levels. The strain also produces antimicrobial compounds like reuterin that inhibit pathogenic bacteria while promoting beneficial microbiome diversity. Additionally, it enhances intestinal barrier function by stimulating tight junction proteins and reducing inflammatory cytokines.

Scientific Research

Research shows Lactobacillus reuteri NCIMB 30242 may help lower cholesterol levels and support gut health, with studies supporting its probiotic benefits.

Clinical Summary

A randomized controlled trial with 127 adults showed Lactobacillus reuteri NCIMB 30242 supplementation for 9 weeks reduced LDL cholesterol by 9% and total cholesterol by 5% compared to placebo. The same study demonstrated improved gut microbiome diversity with increased beneficial Bifidobacterium and reduced pathogenic species. Additional studies have shown improvements in inflammatory markers including reduced C-reactive protein levels. While promising, most research involves relatively small sample sizes and short-term interventions.

Nutritional Profile

- Available in probiotic supplements and some dairy products. - Contains live bacteria beneficial for heart and gut health. - Often combined with other probiotics for enhanced effects.

Preparation & Dosage

Typically consumed in doses of 1-10 billion CFU per day. Consult a healthcare provider before use.

Synergy & Pairings

Cholesterol-lowering foods, Bifidobacterium, Prebiotics, Gut microbiota, Heart health

Safety & Interactions

Lactobacillus reuteri NCIMB 30242 is generally well-tolerated with mild digestive symptoms like bloating or gas reported in some individuals during initial supplementation. No significant drug interactions have been documented, though individuals taking immunosuppressive medications should consult healthcare providers before use. The strain appears safe for most healthy adults, but safety data during pregnancy and lactation is limited. People with severe immunocompromised conditions should avoid probiotic supplementation without medical supervision.